Liminatus Pharma, Inc. Class A Common Stock (LIMN) — Stock Valuation & Research

Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.

LIMN key statistics

Price$2.66
Market cap$3.57M
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
52-week range2.4035-141.5
Beta0.75

Explore LIMN's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.